Rep. Allen Pricing Focus Shifts From FSS To Medicare Rx Plans
Executive Summary
Private-insurance based Medicare proposals do not offer enough leverage on price, Rep. Allen (D-Maine) told a May 3 briefing on health care sponsored by the Council for Affordable Health Insurance in Washington, D.C.
You may also be interested in...
HHS Price-Setting Regs Could Be Authorized Under Democratic Medicare Plan
House Democrats are considering whether legislation to create a PBM-administered Medicare prescription drug benefit should allow HHS to issue rules ensuring that the Medicare program receives drugs at the same prices as other large group purchasers.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011